IDEAYA Biosciences
IDYA
207 hedge funds and large institutions have $1.54B invested in IDEAYA Biosciences in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 104 increasing their positions, 49 reducing their positions, and 25 closing their positions.
144% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $585K
112% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 49
4% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 25
0.85% more ownership
Funds ownership: 106.39% → 107.24% (+0.85%)
0% more funds holding
Funds holding: 206 → 207 (+1)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
35% less capital invested
Capital invested by funds: $2.36B → $1.54B (-$821M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$33.1M |
| 2 |
BlackRock
New York
|
+$16.6M |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$14.9M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.6M |
| 5 |
DM
Deerfield Management
New York
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$20.1M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$14.5M |
| 3 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$13.5M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$10.4M |
| 5 |
Jennison Associates
New York
|
-$9.54M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RS
226
R Squared
Central,
Hong Kong
| – | -$34.7K | -1,350 | Closed |
|
|
BL
227
BFSG LLC
Irvine,
California
| – | -$10.3K | -400 | Closed |
|
228
Bessemer Group
Woodbridge,
New Jersey
| – | -$1K | -50 | Closed |
|
229
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1.13K | -44 | Closed |
|
|
PWA
230
Physician Wealth Advisors
Midvale,
Utah
| – | -$797 | -31 | Closed |
|
|
LFG
231
Larson Financial Group
St Louis,
Missouri
| – | -$745 | -29 | Closed |
|
|
RTC
232
Riverview Trust Company
Vancouver,
Washington
| – | -$488 | -19 | Closed |
|
IDYA Hedge Fund Activity: Q1 2025 in Review
207 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2025, worth a combined $1.54B — down 35% from $2.36B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new IDYA positions and 25 closed out — a net gain of 1 holder — while 104 added to existing stakes and 49 trimmed.
The largest buyer was Sofinnova Investments, adding an estimated $33.1M. The largest seller was Goldman Sachs, cutting an estimated $20.1M.
- 207 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2025, up from 206 in Q4 2024.
- Funds reported $1.54B of IDEAYA Biosciences stock for Q1 2025, down 35% quarter-over-quarter.
- 26 funds opened new IDEAYA Biosciences positions in Q1 2025 and 25 closed out, a net change of +1 holder.
- The largest IDEAYA Biosciences buyer in Q1 2025 was Sofinnova Investments, an estimated $33.1M added.
- The largest IDEAYA Biosciences seller in Q1 2025 was Goldman Sachs, an estimated $20.1M sold.
Based on aggregated 13F filings for Q1 2025.